← Eichor
Study identifier: NCT00843375 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Condition: Colonic Neoplasms  ·  Sponsor: University of Michigan Rogel Cancer Center

PhaseN/A
Planned participants1200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Colon cancer is the second most common cancer in men and women. It is a disease that can be prevented if it is found early. Colonoscopy is still the best screening tool for colon cancer and the polyps that turn into colon cancer. However, due to a variety of factors, including affordability, time, and age, not all patients are able to be screened. Researchers are working on other options for early detection that are as accurate as colonoscopy. The purpose of this study if to determine if stool or blood can be used to detect colon cancers as early or earlier than colonoscopy. The researchers plan to use these samples to learn about specific proteins (also known as biomarkers) that may indicate colon polyps, colon cancer or an increased risk of developing colon cancer. In order to learn more about preventing and detecting colon and rectal cancer, we are collecting samples from subjects with cancer, adenomas, and colonoscopies who may be at risk for polyps.

This description comes directly from the study's public registry record.

Talk to the study team

Cancer AnswerLine  ·  1-800-865-1125  ·  CancerAnswerLine@med.umich.edu

Always discuss trial participation with your own doctor first.

Locations (13)

Cedars-Sinai Medical CenterLos Angeles, California, United StatesRecruiting
Carle Cancer CenterUrbana, Illinois, United StatesCompleted
Dana Farber Cancer InstituteBoston, Massachusetts, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
University of MinnesotaMinneapolis, Minnesota, United StatesRecruiting
NYU Langone HealthNew York, New York, United StatesRecruiting
University of North CarolinaChapel Hill, North Carolina, United StatesCompleted
Oregon Health and Science UniversityPortland, Oregon, United StatesRecruiting
Hershey Medical CenterHershey, Pennsylvania, United StatesCompleted
M.D. Anderson Cancer CenterHouston, Texas, United StatesRecruiting
University of WashingtonSeattle, Washington, United StatesRecruiting
Flinders Medical CenterAdelaide, South Australia, AustraliaRecruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00843375